In summary, this study showed a novel Septin9 methylation assay (ColonUSK) which designed for CRC screening, specifically focusing on the simultaneous detection of two different CpG islands of the Septin9 gene in plasma samples. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.